Can a cell therapy shrink Hard-to-Treat lung tumors?
Disease control
Stopped early
This early-stage trial tests an experimental cell therapy called GAIA-102 in people with advanced or relapsed non-small cell lung cancer. Researchers give GAIA-102 alone or with the immunotherapy drug pembrolizumab to see if the combination is safe and can shrink tumors. The stud…
Phase 1/2 • Sponsor: GAIA BioMedicine Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC